<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>University of Isfahan</PublisherName>
				<JournalTitle>Journal of Microbial Biology</JournalTitle>
				<Issn>3060-7647</Issn>
				<Volume>1</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>01</Month>
					<Day>20</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Priliminary Pages ( 1 st.Year No.4)</ArticleTitle>
<VernacularTitle>Priliminary Pages ( 1 st.Year No.4)</VernacularTitle>
			<FirstPage>0</FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">19493</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2016</Year>
					<Month>06</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract></Abstract>
			<OtherAbstract Language="FA"></OtherAbstract>
<ArchiveCopySource DocType="pdf">https://bjm.ui.ac.ir/article_19493_57c683232bf542d6bfebd1eccc3aed10.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>University of Isfahan</PublisherName>
				<JournalTitle>Journal of Microbial Biology</JournalTitle>
				<Issn>3060-7647</Issn>
				<Volume>1</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>01</Month>
					<Day>20</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Synergistic antibacterial effects of Î²-Chloro-L-alanine and phosphomycin on urinary tract isolates of E. coli</ArticleTitle>
<VernacularTitle>Synergistic antibacterial effects of Î²-Chloro-L-alanine and phosphomycin on urinary tract isolates of E. coli</VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>6</LastPage>
			<ELocationID EIdType="pii">19487</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Nima</FirstName>
					<LastName>Hosseini Jazani</LastName>
<Affiliation>Associate Professor of Microbiology, Urmia University of Medical Sciences, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Omid</FirstName>
					<LastName>Hadizadeh</LastName>
<Affiliation>Medical student, Student&amp;#039;s Research Committee, Urmia University of Medical Sciences, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hamed</FirstName>
					<LastName>Farzaneh</LastName>
<Affiliation>Medical student, Student&amp;#039;s Research Committee, Urmia University of Medical Sciences, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Milad</FirstName>
					<LastName>Moloudizargari</LastName>
<Affiliation>Veterinary Student, Urmia University, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2016</Year>
					<Month>06</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>Â  Introduction : The aim of this study was the evaluation of the synergistic effect of sub-MIC doses of Phosphomycin with Î²-Chloro-L-alanine against urinary tract isolates of E.Â coli.Â Â  Materials and method s: A total of 40 isolates were collected from urine specimens submitted to the clinical diagnostic Laboratories in Urmia, Iran.Â The amounts of MIC and MBC for Phosphomycin, Î²-Chloro-L-alanine or a mixture of 0 . 5 mM Î²-Chloro-L-alanine with sub-MIC doses of Phosphomycin were determined and three groups were compared.Â Â  Results : Of 40 E.Â coli isolates, 12.Â 5 % were susceptible to all investigated concentrations of phosphomycin and 2.Â 5 % were resistant.Â The mean MIC value for phosphomycin in the other E.Â coli isolates was determined as 25.Â 7Â± 35.Â 5 Âµg/ mL.Â All of the bacterial isolates were resistant to all investigated concentrations of Î²-Chloro-L-alanine.Â Application of Î²-Chloro-L-alanine and phosphomycin combination decreased the MIC and MBC values in 22.Â 5 % of the isolates.Â Â  Discussion and conclusion : This study suggests that Î²-Chloro-L-alanine and phosphomycin combination have in vitro synergistic effect on some isolates of urinary tract E.Â coli.Â </Abstract>
			<OtherAbstract Language="FA">Â  Introduction : The aim of this study was the evaluation of the synergistic effect of sub-MIC doses of Phosphomycin with Î²-Chloro-L-alanine against urinary tract isolates of E.Â coli.Â Â  Materials and method s: A total of 40 isolates were collected from urine specimens submitted to the clinical diagnostic Laboratories in Urmia, Iran.Â The amounts of MIC and MBC for Phosphomycin, Î²-Chloro-L-alanine or a mixture of 0 . 5 mM Î²-Chloro-L-alanine with sub-MIC doses of Phosphomycin were determined and three groups were compared.Â Â  Results : Of 40 E.Â coli isolates, 12.Â 5 % were susceptible to all investigated concentrations of phosphomycin and 2.Â 5 % were resistant.Â The mean MIC value for phosphomycin in the other E.Â coli isolates was determined as 25.Â 7Â± 35.Â 5 Âµg/ mL.Â All of the bacterial isolates were resistant to all investigated concentrations of Î²-Chloro-L-alanine.Â Application of Î²-Chloro-L-alanine and phosphomycin combination decreased the MIC and MBC values in 22.Â 5 % of the isolates.Â Â  Discussion and conclusion : This study suggests that Î²-Chloro-L-alanine and phosphomycin combination have in vitro synergistic effect on some isolates of urinary tract E.Â coli.Â </OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">E. coli</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">β-Chloro-L-alanine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">β</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Chloro</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">L</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">alanine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Phosphomycin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Synergistic effect</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://bjm.ui.ac.ir/article_19487_9f40def9842311b0575a7e5a0e169aa0.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>University of Isfahan</PublisherName>
				<JournalTitle>Journal of Microbial Biology</JournalTitle>
				<Issn>3060-7647</Issn>
				<Volume>1</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>01</Month>
					<Day>20</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Cloning and expression of the immunogenic moiety of Pseudomonas aeruginosa exotoxin A</ArticleTitle>
<VernacularTitle>Cloning and expression of the immunogenic moiety of Pseudomonas aeruginosa exotoxin A</VernacularTitle>
			<FirstPage>7</FirstPage>
			<LastPage>14</LastPage>
			<ELocationID EIdType="pii">19491</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Sahar</FirstName>
					<LastName>Nouri Gharajelar</LastName>
<Affiliation>DVSc Student of Microbiology, Urmia University, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Malahat</FirstName>
					<LastName>Ahmadi</LastName>
<Affiliation>Associate Professor of Microbiology, Urmia University, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Bahman</FirstName>
					<LastName>Hosseini</LastName>
<Affiliation>Assistant Professor of Biotechnology, Urmia University, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2016</Year>
					<Month>06</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>Â  Introduction : Pseudomonas aeruginosa, as an opportunistic microorganism, is a major cause of nosocomial infections worldwide. Exotoxin A (ETA) is an extracellular enzyme that is produced by most clinical strains of P. aeruginosa. Although the pathogenesis of the diseases due toÂ Pseudomonas are complex, clinical and experimental data linking ETA with the morbid and lethal consequences ofÂ Pseudomonas infection are accumulating. Â  Materials and method s: An immunogenic 490âbp DNA segment including translocation domain plus 1b domain of the ETA from P. aeruginosa strain PAO1 were reproduced by PCR. The PCR product was cloned in E.coli DH5Î± and expressed in E.coli BL21 using recombinant pET28a vector. The cloned polypeptide was found to have an electrophoretic mobility in sodium dodecyle sulfate- polyacrylamide gels (SDS -PAGE) of 18kDa. Â  Results : PCR and colony PCR results approved the cloning of immunogenic moiety of exotoxin A. Analysis of the location of cloned polypeptide by SDS- PAGE electrophoresis revealed that it was exported by E.coli into the bacterial periplasmic space. Discussion and conclusion : Since the whole toxin is not necessary for enhancing the immune responses and this recombinant polypeptide has antigenic qualities, so it may serve as a useful vaccine to prevent Pseudomonas infections.</Abstract>
			<OtherAbstract Language="FA">Â  Introduction : Pseudomonas aeruginosa, as an opportunistic microorganism, is a major cause of nosocomial infections worldwide. Exotoxin A (ETA) is an extracellular enzyme that is produced by most clinical strains of P. aeruginosa. Although the pathogenesis of the diseases due toÂ Pseudomonas are complex, clinical and experimental data linking ETA with the morbid and lethal consequences ofÂ Pseudomonas infection are accumulating. Â  Materials and method s: An immunogenic 490âbp DNA segment including translocation domain plus 1b domain of the ETA from P. aeruginosa strain PAO1 were reproduced by PCR. The PCR product was cloned in E.coli DH5Î± and expressed in E.coli BL21 using recombinant pET28a vector. The cloned polypeptide was found to have an electrophoretic mobility in sodium dodecyle sulfate- polyacrylamide gels (SDS -PAGE) of 18kDa. Â  Results : PCR and colony PCR results approved the cloning of immunogenic moiety of exotoxin A. Analysis of the location of cloned polypeptide by SDS- PAGE electrophoresis revealed that it was exported by E.coli into the bacterial periplasmic space. Discussion and conclusion : Since the whole toxin is not necessary for enhancing the immune responses and this recombinant polypeptide has antigenic qualities, so it may serve as a useful vaccine to prevent Pseudomonas infections.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Pseudomonas aeruginosa PAO1</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cloning</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Exotoxin A</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Immunogenic moiet</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://bjm.ui.ac.ir/article_19491_e43ea8724f39ae783525912c4fb1014e.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>University of Isfahan</PublisherName>
				<JournalTitle>Journal of Microbial Biology</JournalTitle>
				<Issn>3060-7647</Issn>
				<Volume>1</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>01</Month>
					<Day>20</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Serological survey of human Toxoplasma gondii infection in northern and central regions of Iran</ArticleTitle>
<VernacularTitle>Serological survey of human Toxoplasma gondii infection in northern and central regions of Iran</VernacularTitle>
			<FirstPage>15</FirstPage>
			<LastPage>20</LastPage>
			<ELocationID EIdType="pii">19489</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Khodadad</FirstName>
					<LastName>Pirali-Kheirabadi</LastName>
<Affiliation>Associate Professor of Parasitology, Shahrekord University, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hossein</FirstName>
					<LastName>Tahmasby</LastName>
<Affiliation>DVM, University of Shahrekord, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Kurosh</FirstName>
					<LastName>Manouchehri-Naeini</LastName>
<Affiliation>Associate Professor of Medical Parasitology, Shahrekord University of Medical Sciences, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Saeid</FirstName>
					<LastName>Masoumi-Ghajari</LastName>
<Affiliation></Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2016</Year>
					<Month>06</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Introduction&lt;/strong&gt;: &lt;em&gt;Toxoplasma gondii&lt;/em&gt; is an important zoonotic protozoan parasite that can infect man and animals. The pathogen can infect the fetus by congenital transmission during pregnancy. The aim of this study was to investigate &lt;em&gt;T. gondii&lt;/em&gt; infection in people referred to health care centers in northern and central regions of Iran.
&lt;strong&gt;Materials and method&lt;/strong&gt;s: Serum samples from 712 individuals in Mazandaran, Isfahan and ChaharmahalvaBakhtiari provinces, Iran, were examined for the levels of anti-&lt;em&gt;T. Gondii &lt;/em&gt;IgG by ELISA. Prevalence of &lt;em&gt;T. gondii&lt;/em&gt; infection in respect of gender and age was analyzed&lt;sup&gt;. &lt;/sup&gt;
&lt;strong&gt;Results&lt;/strong&gt;: The overall anti&lt;strong&gt;-&lt;/strong&gt;&lt;em&gt;T. gondii &lt;/em&gt;IgG prevalence in the study population was 72.05%. In Mazandaran, Isfahan and ChaharmahalvaBakhtiari provinces,in male population respectively 87.6, 41.46 and 61.81% and in female population respectively 89.31, 47.61 and 64.44% were sero-positive with anti-&lt;em&gt;T. gondii &lt;/em&gt;IgG. Sero-prevalance of anti-&lt;em&gt;T.gondii &lt;/em&gt;IgG in the females was higher than in the males in the northern and central regions of Iran&lt;sup&gt;. &lt;/sup&gt;
&lt;strong&gt;Discussion and conclusion&lt;/strong&gt;&lt;strong&gt;:&lt;/strong&gt;The present study demonstrates high prevalence of &lt;em&gt;Toxoplasma&lt;/em&gt; infection in northern and central regions of Iran and a higher prevalence of &lt;em&gt;T. gondii&lt;/em&gt; infection was observed in females. Significant difference in infection rate between individuals living in northern and central areas in Iran was found (&lt;em&gt;p &lt;/em&gt;&lt;0.05), which indicated that &lt;em&gt;T. gondii&lt;/em&gt; infection is dependent on living places. Deeper investigations for the potential risk factors that threat the Iranian populations, especially female are recommended.</Abstract>
			<OtherAbstract Language="FA">&lt;strong&gt;Introduction&lt;/strong&gt;: &lt;em&gt;Toxoplasma gondii&lt;/em&gt; is an important zoonotic protozoan parasite that can infect man and animals. The pathogen can infect the fetus by congenital transmission during pregnancy. The aim of this study was to investigate &lt;em&gt;T. gondii&lt;/em&gt; infection in people referred to health care centers in northern and central regions of Iran.
&lt;strong&gt;Materials and method&lt;/strong&gt;s: Serum samples from 712 individuals in Mazandaran, Isfahan and ChaharmahalvaBakhtiari provinces, Iran, were examined for the levels of anti-&lt;em&gt;T. Gondii &lt;/em&gt;IgG by ELISA. Prevalence of &lt;em&gt;T. gondii&lt;/em&gt; infection in respect of gender and age was analyzed&lt;sup&gt;. &lt;/sup&gt;
&lt;strong&gt;Results&lt;/strong&gt;: The overall anti&lt;strong&gt;-&lt;/strong&gt;&lt;em&gt;T. gondii &lt;/em&gt;IgG prevalence in the study population was 72.05%. In Mazandaran, Isfahan and ChaharmahalvaBakhtiari provinces,in male population respectively 87.6, 41.46 and 61.81% and in female population respectively 89.31, 47.61 and 64.44% were sero-positive with anti-&lt;em&gt;T. gondii &lt;/em&gt;IgG. Sero-prevalance of anti-&lt;em&gt;T.gondii &lt;/em&gt;IgG in the females was higher than in the males in the northern and central regions of Iran&lt;sup&gt;. &lt;/sup&gt;
&lt;strong&gt;Discussion and conclusion&lt;/strong&gt;&lt;strong&gt;:&lt;/strong&gt;The present study demonstrates high prevalence of &lt;em&gt;Toxoplasma&lt;/em&gt; infection in northern and central regions of Iran and a higher prevalence of &lt;em&gt;T. gondii&lt;/em&gt; infection was observed in females. Significant difference in infection rate between individuals living in northern and central areas in Iran was found (&lt;em&gt;p &lt;/em&gt;&lt;0.05), which indicated that &lt;em&gt;T. gondii&lt;/em&gt; infection is dependent on living places. Deeper investigations for the potential risk factors that threat the Iranian populations, especially female are recommended.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Toxoplasma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">prevalence</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">risk factor</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">infection</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://bjm.ui.ac.ir/article_19489_a6b5e5531f66a5206a9bc02867c2d2b3.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>University of Isfahan</PublisherName>
				<JournalTitle>Journal of Microbial Biology</JournalTitle>
				<Issn>3060-7647</Issn>
				<Volume>1</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>01</Month>
					<Day>20</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Product optimization, purification and characterization of a novel polygalacturonase produced by Macrophomina phaseolina</ArticleTitle>
<VernacularTitle>Product optimization, purification and characterization of a novel polygalacturonase produced by Macrophomina phaseolina</VernacularTitle>
			<FirstPage>21</FirstPage>
			<LastPage>34</LastPage>
			<ELocationID EIdType="pii">19490</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Saeed</FirstName>
					<LastName>Aminzade</LastName>
<Affiliation>Assistant Professor in Biochemistry, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Naser</FirstName>
					<LastName>Farrokhi</LastName>
<Affiliation>Assistant Professor in Molecular Biology, Shahrood University, Shahrood, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2016</Year>
					<Month>06</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>Introduction : Production of a novel polygalacturonase (PG) active at pH = 3.0 and suitable to be used in fruit juice industries from Macrophomina phaseolina was evaluated. Suitable carbon, nitrogen and phosphorous forms were determined and the condition was optimized for higher PG production. Â  Materials and method s: Macrophomina phaseolina was cultured in so called production medium. The secretome was separated from fungal cells and polygalacturonase was isolated via column chromatography. The biochemical activity of both secretome and isolated polygalacturonase were assayed calorimetrically. The production of polygalacturonase was optimized via changes in culture medium in terms of contents, pH and temperature and Taguchi analysis of data. Enzyme kinetics was partially performed followed by the determination of pH and temperature stability. Â  Results : A range of sugars except glucose and chitin demonstrated to improve the PG production. Ammonium sulfate and peptone demonstrated to be suitable nitrogen sources. Amongst phosphorous sources, dipotassium hydrogen phosphate had the greatest effect. Taguchiâs orthogonal array demonstrated that pH, temperature, ammonium sulfate and trace elements had significant effect on PG production. Furthermore, mean comparisons showed that the optimum condition achieved at pH 6.0, 35 Â°C, 2 g.l-1 ammonium sulfate and 2 mg.l-1 trace elements. Â  Discussion and conclusion : The purified PG with a relative molecular mass of 70 kDa was demonstrated its highest activity at pH = 3, and 30 Â°C. Amongst tested cations and chemicals, Fe2+ improved the enzyme activity by 2 fold, while the secretome responded differently.</Abstract>
			<OtherAbstract Language="FA">Introduction : Production of a novel polygalacturonase (PG) active at pH = 3.0 and suitable to be used in fruit juice industries from Macrophomina phaseolina was evaluated. Suitable carbon, nitrogen and phosphorous forms were determined and the condition was optimized for higher PG production. Â  Materials and method s: Macrophomina phaseolina was cultured in so called production medium. The secretome was separated from fungal cells and polygalacturonase was isolated via column chromatography. The biochemical activity of both secretome and isolated polygalacturonase were assayed calorimetrically. The production of polygalacturonase was optimized via changes in culture medium in terms of contents, pH and temperature and Taguchi analysis of data. Enzyme kinetics was partially performed followed by the determination of pH and temperature stability. Â  Results : A range of sugars except glucose and chitin demonstrated to improve the PG production. Ammonium sulfate and peptone demonstrated to be suitable nitrogen sources. Amongst phosphorous sources, dipotassium hydrogen phosphate had the greatest effect. Taguchiâs orthogonal array demonstrated that pH, temperature, ammonium sulfate and trace elements had significant effect on PG production. Furthermore, mean comparisons showed that the optimum condition achieved at pH 6.0, 35 Â°C, 2 g.l-1 ammonium sulfate and 2 mg.l-1 trace elements. Â  Discussion and conclusion : The purified PG with a relative molecular mass of 70 kDa was demonstrated its highest activity at pH = 3, and 30 Â°C. Amongst tested cations and chemicals, Fe2+ improved the enzyme activity by 2 fold, while the secretome responded differently.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Macrophomina phaseolina</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">polygalacturonase</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">fruit juice industry</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Taguchi orthogonal method</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">purification and characterization</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://bjm.ui.ac.ir/article_19490_0c4ff8dcc0d265cf082a8f9a764f0f8e.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>University of Isfahan</PublisherName>
				<JournalTitle>Journal of Microbial Biology</JournalTitle>
				<Issn>3060-7647</Issn>
				<Volume>1</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>01</Month>
					<Day>20</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Optimization of nicotinamide and riboflavin in the biodesulfurization of dibenzothiophene using response surface methodology</ArticleTitle>
<VernacularTitle>Optimization of nicotinamide and riboflavin in the biodesulfurization of dibenzothiophene using response surface methodology</VernacularTitle>
			<FirstPage>35</FirstPage>
			<LastPage>40</LastPage>
			<ELocationID EIdType="pii">19488</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Peyman</FirstName>
					<LastName>Derikvand</LastName>
<Affiliation>MSc. of Microbiology, University of Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Zahra</FirstName>
					<LastName>Etemedifar</LastName>
<Affiliation>Assistant Professor of Microbiology, University of Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hossein</FirstName>
					<LastName>Saber</LastName>
<Affiliation>MSc. of Microbial Biotechnology, University of Isfahan, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2016</Year>
					<Month>06</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>Â  Dibenzothiophene (DBT) is a sulfuric compound and resistant to Hydrodesulfurization process.Rhodococcuserythropolis R1, a previously isolated bacterial strain, is capable to bioconversion of DBT to 2-hydroxybiphenyl (2-HBP) . Â  Materials and method s: The effect of nicotinamide (precursor of NAD) and riboflavin (precursor of FMN) on DBT biodesulfurization and growth rate by this strain was studied using Gibbs assay and turbidimeteric assay respectively. The level of cofactor precursors were optimized using response surface methodology (RSM) . Â  Results : Analyses showed that both nicotinamide and riboflavin were statistically significant and could enhance the biodesulfurization rate of DBT by induction of dsz operon. The optimum level of nicotinamide and riboflavin was obtained at 10.67 mM and 34.2 ÂµM respectively . Â  Discussion and conclusion : In spite of increasing in BDS, the addition of these cofactor precursors led to decreased growth rate and biomass production due to limitated effect of produced 2-HBP. Â </Abstract>
			<OtherAbstract Language="FA">Â  Dibenzothiophene (DBT) is a sulfuric compound and resistant to Hydrodesulfurization process.Rhodococcuserythropolis R1, a previously isolated bacterial strain, is capable to bioconversion of DBT to 2-hydroxybiphenyl (2-HBP) . Â  Materials and method s: The effect of nicotinamide (precursor of NAD) and riboflavin (precursor of FMN) on DBT biodesulfurization and growth rate by this strain was studied using Gibbs assay and turbidimeteric assay respectively. The level of cofactor precursors were optimized using response surface methodology (RSM) . Â  Results : Analyses showed that both nicotinamide and riboflavin were statistically significant and could enhance the biodesulfurization rate of DBT by induction of dsz operon. The optimum level of nicotinamide and riboflavin was obtained at 10.67 mM and 34.2 ÂµM respectively . Â  Discussion and conclusion : In spite of increasing in BDS, the addition of these cofactor precursors led to decreased growth rate and biomass production due to limitated effect of produced 2-HBP. Â </OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Rhodococcus erythropolis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Nicotinamide</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Riboflavin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Dibenzothiophene</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://bjm.ui.ac.ir/article_19488_94fbfb5a1b22ee5cd13596f4bcdc38bf.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>University of Isfahan</PublisherName>
				<JournalTitle>Journal of Microbial Biology</JournalTitle>
				<Issn>3060-7647</Issn>
				<Volume>1</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>01</Month>
					<Day>20</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The correlation of Mycolic acid production by a toluene degrading Mycobacterium in the presence of cholesterol</ArticleTitle>
<VernacularTitle>The correlation of Mycolic acid production by a toluene degrading Mycobacterium in the presence of cholesterol</VernacularTitle>
			<FirstPage>41</FirstPage>
			<LastPage>48</LastPage>
			<ELocationID EIdType="pii">19492</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Giti</FirstName>
					<LastName>Emtiazi</LastName>
<Affiliation>Full professor of Microbiology, university of Isfahan, Iran,</Affiliation>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Fanaei</LastName>
<Affiliation>M.Sc. of Microbiology, University of Isfahan, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Azar</FirstName>
					<LastName>Farhang Esfahani</LastName>
<Affiliation>M.Sc. of Microbiology, Islamic Azad University, Falavarjan Branch, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Zarindokht</FirstName>
					<LastName>Emami</LastName>
<Affiliation>Ph.D. student of Microbiology, Islamic Azad University, Falavarjan Branch, Isfahan, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2016</Year>
					<Month>06</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>Â  Introduction : Cell wall mycolic acids (MA) from Mycobacterium tuberculosis are presented as antigens that can be used to detect antibodies as surrogate markers of active Tuberculosis (TB) disease, even in HIV coinfected patients. The use of the complex mixtures of natural MA is complicated by apparent antibody cross-reactivity with cholesterol. Mycolic acid is not only related to diagnosis of TB disease but also similar structure of mycolic acid in saprophyte strains are excellent candidate for drug delivery especially for nasal spray. The aim of this work was to investigate the effect of cholesterol on mycolic acid synthesis and potential of saprophyte mycolic acid to drug delivery. Â  Materials and method s: Toluene enrichment medium was used for isolation of mycolic acid producing bacteria. A fast growing, acid fast bacterium was identified by PCR reaction and the related sequence of 16S rRNA gene was deposited in the NCBI Genbank with accession number jn64433. Production of mycolic acid was investigated by high-performance liquid chromatography (HPLC) in different media.Â Â  Results : Here the effect of cholesterol on biosynthesis of mycolic acids by saprophyte Mycobacterium isolated from marine water is was reported. HPLC analyses showed the mycolic acid extracted from saprophyte. Mycobacterium had one, early, cluster of peaks, like Mycobacterium tuberculosis and Mobacterium bovis.This strain is a fast growing bacterium and cholesterol might promote longer fatty acid production.Â Discussion and conclusion : The similarity between mycolic acid from isolated and patogenic mycobacteria offers that mycolic acid obtained from saprophyte Mycobacterium can be useful as a drug carrier. Addition of egg yolk to media induced longer fatty acid production by isolating that is suitable for delivery of drugs into the macrophage.</Abstract>
			<OtherAbstract Language="FA">Â  Introduction : Cell wall mycolic acids (MA) from Mycobacterium tuberculosis are presented as antigens that can be used to detect antibodies as surrogate markers of active Tuberculosis (TB) disease, even in HIV coinfected patients. The use of the complex mixtures of natural MA is complicated by apparent antibody cross-reactivity with cholesterol. Mycolic acid is not only related to diagnosis of TB disease but also similar structure of mycolic acid in saprophyte strains are excellent candidate for drug delivery especially for nasal spray. The aim of this work was to investigate the effect of cholesterol on mycolic acid synthesis and potential of saprophyte mycolic acid to drug delivery. Â  Materials and method s: Toluene enrichment medium was used for isolation of mycolic acid producing bacteria. A fast growing, acid fast bacterium was identified by PCR reaction and the related sequence of 16S rRNA gene was deposited in the NCBI Genbank with accession number jn64433. Production of mycolic acid was investigated by high-performance liquid chromatography (HPLC) in different media.Â Â  Results : Here the effect of cholesterol on biosynthesis of mycolic acids by saprophyte Mycobacterium isolated from marine water is was reported. HPLC analyses showed the mycolic acid extracted from saprophyte. Mycobacterium had one, early, cluster of peaks, like Mycobacterium tuberculosis and Mobacterium bovis.This strain is a fast growing bacterium and cholesterol might promote longer fatty acid production.Â Discussion and conclusion : The similarity between mycolic acid from isolated and patogenic mycobacteria offers that mycolic acid obtained from saprophyte Mycobacterium can be useful as a drug carrier. Addition of egg yolk to media induced longer fatty acid production by isolating that is suitable for delivery of drugs into the macrophage.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Mycobacterium</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Toluene</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Mycolic acid</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cholesterol</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://bjm.ui.ac.ir/article_19492_4c81b509d2fd64ebcf5753a6b933e1e4.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
